The following pages link to Lindi M. Wahl (Q329370):
Displaying 24 items.
- (Q253628) (redirect page) (← links)
- Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects (Q253629) (← links)
- Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects (Q263490) (← links)
- Extinction probabilities and stationary distributions of mobile genetic elements in prokaryotes: the birth-death-diversification model (Q304427) (← links)
- Backward bifurcations, turning points and rich dynamics in simple disease models (Q329371) (← links)
- Monte Carlo estimates of natural variation in HIV infection (Q776589) (← links)
- The effects of genetic drift in experimental evolution (Q851298) (← links)
- Improving estimates of the basic reproductive ratio: Using both the mean and the dispersal of transition times (Q851428) (← links)
- Estimating the optimal bottleneck ratio for experimental evolution: the burst-death model (Q933275) (← links)
- The impact of host-cell dynamics on the fixation probability for lytic viruses (Q1624559) (← links)
- The impact of population bottlenecks on microbial adaptation (Q1668959) (← links)
- Topology of whole-brain functional MRI networks: improving the truncated scale-free model (Q1782811) (← links)
- The time distribution of sulfadoxine-pyrimethamine protection from malaria (Q1936709) (← links)
- Quantifying the forces that maintain prophages in bacterial genomes (Q2185205) (← links)
- Dynamical analysis and simulation of a 2-dimensional disease model with convex incidence (Q2198884) (← links)
- Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells (Q2202354) (← links)
- Optimal drug treatment regimens for HIV depend on adherence (Q2210076) (← links)
- The impact of prophage on the equilibria and stability of phage and host (Q2359420) (← links)
- Costs versus benefits: best possible and best practical treatment regimens for HIV (Q2373250) (← links)
- Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting'' (Q2426381) (← links)
- Self-tolerance and autoimmunity in a regulatory T cell model (Q2430570) (← links)
- Conditions for Transient Viremia in Deterministic in-Host Models: Viral Blips Need No Exogenous Trigger (Q2841005) (← links)
- Mathematical modelling of CRISPR-Cas system effects on biofilm formation (Q3304374) (← links)
- Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: parameter estimates, identifiability, sensitivity and the eclipse phase profile (Q6174182) (← links)
